The FDA’s next move, $549 headphones and overly optimistic?
Pfizer’s COVID-19 vaccinations are underway in the UK, while the FDA is expected to give U.S. approval this week. We’ll break down this monumental rollout. Plus, Apple says its new fitness subscription service will launch next week, and unveils the new $549 Airpods Max. We’ll discuss Apple’s ‘flex’ in Rapid Fire. And, Goldman Sachs raises its GDP outlook, as JPMorgan says any market correction is a buying opportunity. Is the market getting overly optimistic? We’ll debate.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Pfizer’s COVID-19 vaccinations are underway in the UK, while the FDA is expected to give U.S. approval this week. We’ll break down this monumental rollout.
Plus, Apple says its new fitness subscription service will launch next week, and unveils the new $549 Airpods Max. We’ll discuss Apple’s ‘flex’ in Rapid Fire.
And, Goldman Sachs raises its GDP outlook, as JPMorgan says any market correction is a buying opportunity. Is the market getting overly optimistic? We’ll debate.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.